Sponsor or institution

Clinical trials and research at Gruppo Oncologico del Nord-Ovest

• 9Clinical trials
• 4Countries

Newest trials

All recruiting trials (9)

• Postbiotix-HLA™ with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

  This trial will test whether taking the postbiotic supplement Postbiotix-HLA™ with first-line pembrolizumab reduces immune-related side effects and alters microbiota in people with recurrent or metastatic head and neck squamous cell carcinoma.

  Recruiting Phase 2 Gruppo Oncologico del Nord-Ovest · Rozzano, Milano · NCT07485296

• First-line trastuzumab-deruxtecan with capecitabine and bevacizumab for HER2-positive metastatic colorectal cancer

  This trial tests whether giving trastuzumab-deruxtecan together with capecitabine and bevacizumab as first treatment helps people with HER2-positive metastatic or unresectable colorectal cancer shrink tumors and respond better.

  Recruiting at 28 sites Phase 2 Gruppo Oncologico del Nord-Ovest · Lyon and 27 other locations · NCT07407465

• Comparing two chemotherapy approaches for advanced pancreatic cancer

  This study is testing whether switching to a different chemotherapy combination or continuing the current treatment helps people with advanced pancreatic cancer live longer and feel better.

  Recruiting at 9 sites Phase 3 Gruppo Oncologico del Nord-Ovest · Aviano and 27 other locations · NCT06897644

• Combining chemotherapy with cetuximab and avelumab for advanced head and neck cancer

  This study is testing a new treatment plan that combines chemotherapy with two medications, cetuximab and avelumab, to see if it helps people with advanced head and neck cancer live longer without their disease getting worse.

  Recruiting at 3 sites Phase 2 Gruppo Oncologico del Nord-Ovest · Cagliari, CAGLIARI and 7 other locations · NCT06869473

• Combination treatment for metastatic colorectal cancer patients

  This study is testing if adding Atezolizumab to the usual treatment for patients with advanced colorectal cancer can help them live longer without their cancer getting worse.

  Recruiting at 24 sites Phase 3 Gruppo Oncologico del Nord-Ovest · Brescia, BS and 23 other locations · NCT06733038

• Treatment for HER2-positive gastric cancer after surgery

  This study is testing if a new combination treatment can help people with HER2-positive gastric cancer feel better after their surgery if they still have some cancer left.

  Recruiting Phase 2 Gruppo Oncologico del Nord-Ovest · Milan · NCT06253650

• Combination chemotherapy for patients with resectable biliary tract cancers

  This study is testing a new combination of chemotherapy drugs before surgery to see if it helps people with certain types of biliary tract cancers live longer without their cancer coming back.

  Recruiting at 2 sites Phase 2/3 Gruppo Oncologico del Nord-Ovest · Ancona and 18 other locations · NCT06037980

• Targeted treatments for resectable colorectal cancer based on molecular profiles

  This study is testing if personalized treatments based on the specific genetic features of non-metastatic colorectal cancer can help patients do better after surgery.

  Recruiting Phase 2 Gruppo Oncologico del Nord-Ovest · Milan, Lombardia/MI · NCT05845450

• Combination treatment with a PARP inhibitor and immunotherapy for HPV-negative head and neck cancer

  This study is testing a new combination of two treatments for people with HPV-negative head and neck cancer to see if it can help them before and after surgery.

  Recruiting Phase 2 Gruppo Oncologico del Nord-Ovest · Brescia · NCT04681469

Quick answers

How many clinical trials run by Gruppo Oncologico del Nord-Ovest are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Italy (9 trials), France (1 trial), Germany (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →